What is the evidence for the cost-effectiveness of multidisciplinary team (MDT) in patients with heart failure?
22 studies were included in a review of the effect of MDT on the cost-effectiveness of heart failure treatment. The results of the review showed that in patients with less severe heart failure (NYHA class I-II), MDT intervention was more cost-effective than usual care or other interventions. However, in patients with severe heart failure (NYHA class III-IV), usual care was the most cost-effective option. A cost-utility analysis and Markov model was used to assess the cost-effectiveness of MDT. Quality-adjusted life years (QALYs) per QALY was used to measure effects, and costs and effects were discounted at 5%. The results of the study and the conclusions were found to be robust to sensitivity analyses. 